SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001933414-23-000038
Filing Date
2023-05-15
Accepted
2023-05-15 17:25:23
Documents
51
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mlys-20230331.htm   iXBRL 10-Q 706995
2 EX-31.1 mlys-1q2310qex311.htm EX-31.1 9914
3 EX-31.2 mlys-1q2310qex312.htm EX-31.2 9851
4 EX-32.1 mlys-1q2310qex321.htm EX-32.1 5151
5 EX-32.2 mlys-1q2310qex322.htm EX-32.2 5055
  Complete submission text file 0001933414-23-000038.txt   3544952

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20230331.xsd EX-101.SCH 25233
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20230331_cal.xml EX-101.CAL 32867
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20230331_def.xml EX-101.DEF 140721
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20230331_lab.xml EX-101.LAB 308315
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20230331_pre.xml EX-101.PRE 221849
45 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20230331_htm.xml XML 430332
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41614 | Film No.: 23924503
SIC: 2834 Pharmaceutical Preparations